Weimin Zhang - Publications, H-index & Citations

Weimin Zhang

taiyuan university of technology

25H指数

155论文数

2.2K被引数

收录论文 53

发表时间

Defect-Regulated Co/CeO2 Catalysts for Selective Hydrodeoxygenation of Lignin-Derived Phenolics: Unravelling the Interfacial Hydrogenation C–O Cleavage Synergy 缺陷调控的Co/CeO2催化剂用于木质素衍生酚类的选择性加氢脱氧：揭示界面加氢C–O键断裂协同作用

Catalysts

IF4

2026-08-29

OAAI

Weimin Zhang; Yu Feng; Tianjin Li; Jingyu Wang

Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma Chidamide与顺铂-依托泊苷协同作用，在弥漫性大B细胞淋巴瘤中触发焦亡和抗肿瘤免疫

Communications Medicine

IF6.3

2026-04-21

OAAI

Jianbo Wu; Yingying Ye; Danyang Ran; Xing Wang; Hanwen Zhu; Hanmei Zhang; Fuqing Meng; Yalong Song; Zhiwei Li; Lan Mi; Xiaoyuan Zhang; Yixin Qian; Hanrong Li; Xiaowei Tong; Peihuang Wu; Bowen Sun; Xinya Li; Weimin Zhang; Dali Li; Huajun Wu; Yingjie Yu; Yunkun Dang; Fan Lai; Lijuan Deng; Yuqin Song; Jun Zhu; Yan Xie; Mi Deng

Halofuginone is a Molecular Glue Degrader of Integrin β4 盐酸卤夫酮是整合素β4的分子胶降解剂

Advanced Science

IF14.1

2026-03-24

OAAI

Wei Gong; Di Yang; Junrui Tian; Yufei Chai; Tiantian Yu; Qingnan Wu; Yan Wang; Weimin Zhang; Qimin Zhan

The consensus molecular subtypes of esophageal squamous cell carcinoma 食管鳞状细胞癌的共识分子亚型

Signal Transduction and Targeted Therapy

IF52.7

2026-02-19

OAAI

Heyang Cui; Zhongxu Zhu; Enwei Xu; Lin Qi; Yikun Cheng; Yinghan Zhang; Ling Zhang; Matthew Yibo Cheng; Bin Yang; Ruifang Sun; Xiaofei Zhuang; Yanfeng Xi; Ting Yan; Caixia Cheng; Ning Ding; Huijuan Liu; Lu Wang; Min Guo; Dinghe Guo; Haoyu Zhang; Meilan Peng; Zhekun An; Yongjia Weng; Fang Wang; Meng Liu; Ruixin Xiong; Weihua Yin; Bin Song; Weimin Zhang; Xiaolong Cheng; Zhihua Liu; Qimin Zhan; Xin Wang; Yongping Cui

IRF2BPL transcriptionally regulates IGFBP2 to promote tumor progression and suppresses immune cell infiltration in esophageal squamous cell carcinoma IRF2BPL转录调控IGFBP2以促进食管鳞状细胞癌的肿瘤进展并抑制免疫细胞浸润。

Oncogene

IF7.3

2025-12-18

PREAI

Yueguang Wu; Heyang Cui; Longlong Wang; Ning Ding; Yongjia Weng; Yikun Cheng; Shanshan Bi; Heng Xiao; Mingwei Gao; Huijuan Liu; Qiqin Song; Weimin Zhang; Yongping Cui

Emodin inhibits colon cancer tumor growth by suppressing tumor cell glycolysis through inhibition of NAT10-mediated PGK1 ac4C modification Emodin通过抑制NAT10介导的PGK1 ac4C修饰来抑制肿瘤细胞糖酵解，从而抑制结肠癌肿瘤生长。

Frontiers in Oncology

IF3.3

2025-12-05

OAAI

Zhuoxin Wei; Zhuo Lv; Weimin Zhang

Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma 食管鳞状细胞癌中多倍体巨癌细胞的选择性适应和不对称遗传

Cancer Letters

IF10.1

2025-05-23

PREAI

Song, Qiqin; Gao, Mingwei; Weng, Yongjia; Zhuang, Xuehan; Wu, Yueguang; Cui, Heyang; Ding, Ning; Wang, Longlong; Bi, Shanshan; Zhang, Li; Zhang, Weimin; Cui, Yongping

YTHDC1 negatively regulates UBE3A to influence RAD51 ubiquitination and inhibit apoptosis in colorectal cancer cells

SCIENTIFIC REPORTS

IF3.9

2025-03-14

OAAI

Gao, Mingwei; Wu, Yueguang; Zhang, Li; Zhou, Yan; Liu, Huijuan; Zhang, Weimin; Wang, Shubin; Cui, Yongping

APC/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1/S transition

CELL COMMUNICATION AND SIGNALING

IF8.9

2024-05-23

OAAI

Zhao, Huihui; Cheng, Xinxin; Yan, Liping; Mi, Fang; Wang, Wenqing; Hu, Yuying; Liu, Xingyang; Fan, Yuyan; Min, Qingjie; Wang, Yan; Zhang, Weimin; Wu, Qingnan; Zhan, Qimin

Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma

NATIONAL SCIENCE REVIEW

IF17.1

2024-04-23

OAAI

Zhou, Yong; Mo, Shanlan; Cui, Heyang; Sun, Ruifang; Zhang, Weimin; Zhuang, Xiaofei; Xu, Enwei; Li, Hongyi; Cheng, Yikun; Meng, Yongsheng; Liu, Meilin; Yan, Ting; Liu, Huijuan; Zhang, Ling; Yang, Bin; Xi, Yanfeng; Wang, Shubin; Cheng, Xiaolong; Li, Shuaicheng; Liu, Zhihua; Zhan, Qimin; Hu, Zheng; Cui, Yongping

IGH repertoire analysis at scale: deciphering the complexity of B cell infiltration and migration in esophageal squamous cell carcinoma

CANCER GENE THERAPY

IF5

2023-11-20

PREAI

Wang, Longlong; Zhou, Yong; Cui, Heyang; Zhuang, Xuehan; Cheng, Chen; Weng, Yongjia; Liu, Huijuan; Wang, Shubin; Pan, Xinghua; Cui, Yongping; Zhang, Weimin

Dysregulation of cholesterol metabolism in cancer progression 胆固醇代谢失调在癌症进展中的作用

ONCOGENE

IF7.3

2023-09-29

PREAI

Liu, Xuesong; Lv, Mengzhu; Zhang, Weimin; Zhan, Qimin

CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties

Signal Transduction and Targeted Therapy

IF52.7

2023-08-16

OAAI

Mengzhu Lv; Ying Gong; Xuesong Liu; Yan Wang; Qingnan Wu; Jie Chen; Qingjie Min; Dongyu Zhao; Xianfeng Li; Dongshao Chen; Di Yang; Danna Yeerken; Rui Liu; Jinting Li; Weimin Zhang; Qimin Zhan

Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma

CARCINOGENESIS

IF2.9

2023-06-03

PREAI

Chen, Dongshao; Hong, Ruoxi; Cao, Youjun; Wu, Qingnan; Wang, Yan; Chen, Jie; Li, Jinting; Zhang, Weimin; Zhan, Qimin

Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production

MICROBIOLOGY SPECTRUM

IF3.8

2023-04-13

OAAI

Ding, Ning; Cheng, Yikun; Liu, Huijuan; Wu, Yueguang; Weng, Yongjia; Cui, Heyang; Cheng, Chen; Zhang, Weimin; Cui, Yongping

PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-02-01

OAAI

Zhao, Di; Zhang, Jing; Zhang, Lingyuan; Wu, Qingnan; Wang, Yan; Zhang, Weimin; Xiao, Yuanfan; Chen, Jie; Zhan, Qimin

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum (vol 9, pg 1401, 2019)

THERANOSTICS

IF13.3

2023-01-01

OAAI

Zhao, Zitong; Li, Lin; Du, Peina; Ma, Liying; Zhang, Weimin; Zheng, Leilei; Lan, Bo; Zhang, Bailin; Ma, Fei; Xu, Bo; Zhan, Qimin; Song, Yongmei

Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma

NATURE COMMUNICATIONS

IF15.7

2022-10-22

OAAI

Cui, Heyang; Zhou, Yong; Wang, Fang; Cheng, Caixia; Zhang, Weimin; Sun, Ruifang; Zhang, Ling; Bi, Yanghui; Guo, Min; Zhou, Yan; Wang, Xinhui; Ren, Jiaxin; Bai, Ruibing; Ding, Ning; Cheng, Chen; Wang, Longlong; Zhuang, Xuehan; Gao, Mingwei; Weng, Yongjia; Wu, Yueguang; Liu, Huijuan; Li, Shuaicheng; Wang, Shubin; Cheng, Xiaolong; Cui, Yongping; Liu, Zhihua; Zhan, Qimin

Fruquintinib plus sintilimab in refractory repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Preliminary clinical results and biomarker analyses from a phase II study

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Zhang, W.; Sun, Y.; Jiang, Z.; Liu, T.; Gong, C.; Yang, L.; Xin, Y.; Huang, D.; Zhou, A.

Anti-PD-1 antibody SHR-1210 combined with apatinib as adjuvant treatment in patients with hepatocellular carcinoma at high risk of recurrence after radical resection: Preliminary results from a multicenter, randomized, controlled phase II trial

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Zhao, H.; Du, S.; Zhu, Z.; Jiang, L.; Che, X.; Qian, H.; Song, J.; Liu, D.; Zhang, Y.; Zhang, P.; Sun, Y.; Zhang, W.; Tang, Y.

研究方向